[{"NetIncomeLoss_1_Q2_USD":-20320000.0,"DeferredRentCreditCurrent_0_Q2_USD":25000.0,"DepreciationAndAmortization_2_Q2_USD":700000.0,"DepreciationAndAmortization_1_Q2_USD":400000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":6327000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":3046000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":7926818.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":11803778.0,"CommitmentsAndContingencies_0_Q2_USD":null,"AccruedLiabilitiesCurrent_0_Q2_USD":3297000.0,"OperatingLeasesRentExpenseNet_2_Q2_USD":300000.0,"OperatingLeasesRentExpenseNet_1_Q2_USD":200000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_2_Q2_pure":0.89,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_1_Q2_pure":0.89,"InterestPaidNet_2_Q2_USD":7000.0,"FairValueLiabilitiesLevel2ToLevel1TransfersAmount_0_Q2_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_2_Q2_pure":0.014,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-404000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":264079000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":66982.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_2_Q2_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_1_Q2_USD":0.0,"AssetsCurrent_0_Q2_USD":413057000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_2_Q2_shares":66982.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":5172242.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":297000.0,"DueToRelatedPartiesCurrent_0_Q2_USD":102000.0,"CommonStockSharesIssued_0_Q2_shares":50881698.0,"CommonStockDividendsPerShareDeclared_2_Q2_USD":0.0,"Liabilities_0_Q2_USD":33038000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":539965000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":410046000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":363000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":42493000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":18178000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":893000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":1992000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":1358000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":904000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":0.0,"IncomeTaxExpenseBenefit_1_Q2_USD":0.0,"CommonStockValue_0_Q2_USD":54000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":739000.0,"ForeignCurrencyTransactionGainLossBeforeTax_2_Q2_USD":-179000.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q2_USD":-176000.0,"Assets_0_Q2_USD":416248000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":374279000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_2_Q2_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_1_Q2_USD":0.0,"OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear_0_Q2_USD":0.0,"PaymentsOfStockIssuanceCosts_2_Q2_USD":3296000.0,"PaymentsOfStockIssuanceCosts_0_Q2_USD":3300000.0,"FairValueAdjustmentOfWarrants_2_Q2_USD":179000.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_2_Q2_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_1_Q2_USD":0.0,"NetIncomeLossAvailableToCommonStockholdersBasic_2_Q2_USD":-47462000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q2_USD":-20320000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-799000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1_Q2_pure":0.004,"OtherAssetsNoncurrent_0_Q2_USD":438000.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q2_USD":0.0,"ConversionOfStockAmountConverted1_2_Q2_USD":270190000.0,"ShareBasedCompensation_2_Q2_USD":1661000.0,"ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_2_Q2_USD":109879000.0,"CommonStockSharesOutstanding_0_Q2_shares":50881698.0,"FairValueLiabilitiesLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"CapitalLeasesIncomeStatementAmortizationExpense_2_Q2_USD":0.0,"CapitalLeasesIncomeStatementAmortizationExpense_1_Q2_USD":0.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":3496000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":1289000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-22805000.0,"GainLossOnDispositionOfAssets1_2_Q2_USD":-16000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":530000.0,"LiabilitiesCurrent_0_Q2_USD":32894000.0,"AccountsPayableCurrent_0_Q2_USD":2556000.0,"InterestExpense_2_Q2_USD":7000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":410046000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":3011000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_2_Q2_pure":0.812,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_1_Q2_pure":0.868,"ProceedsFromStockOptionsExercised_2_Q2_USD":346000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":290000.0,"IncreaseDecreaseInOtherOperatingAssets_2_Q2_USD":-44000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_2_Q2_pure":0.004,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":195834.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q2_shares":152177.0,"CapitalLeasesFutureMinimumPaymentsDue_0_Q2_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_2_Q2_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_1_Q2_USD":0.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":2753000.0,"NetIncomeLoss_2_Q2_USD":-47462000.0,"AssetImpairmentCharges_2_Q2_USD":267000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":351070000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-156809000.0,"DeferredRentCreditNoncurrent_0_Q2_USD":8000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":8.08,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q2_USD":8.41,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":264000.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"CommonStockSharesAuthorized_0_Q2_shares":66000000.0,"OperatingIncomeLoss_2_Q2_USD":-48820000.0,"OperatingIncomeLoss_1_Q2_USD":-21224000.0,"ProceedsFromIssuanceInitialPublicOffering_0_Q2_USD":264100000.0,"ProceedsFromIssuanceInitialPublicOffering_2_Q2_USD":267375000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_2_Q2_USD":5800000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1_Q2_USD":4500000.0,"InvestmentIncomeInterest_2_Q2_USD":179000.0,"InvestmentIncomeInterest_1_Q2_USD":44000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2_Q2_pure":0.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":1.95,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1_Q2_USD":1.96,"LiabilitiesAndStockholdersEquity_0_Q2_USD":416248000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":731000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":6249000.0,"OperatingExpenses_2_Q2_USD":48820000.0,"OperatingExpenses_1_Q2_USD":21224000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-5.99,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-1.72,"ProfitLoss_2_Q2_USD":-47462000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":136000.0,"StockholdersEquity_0_Q2_USD":383210000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":404000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q2_pure":0.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":1696000.0,"Ticker":"PCVX","CIK":"1649094","name":"VAXCYTE, INC.","OfficialName":"Vaxcyte Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1309224961.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200812"}]